FDA Looks to China to Address Cancer Drug Shortage

According to a recent NBC News article, the FDA is partnering with a Chinese drugmaker, Qilu Pharmaceutical, to import the chemotherapy drug cisplatin in an effort to address the ongoing shortage of the drug in the United States. Cisplatin has been in short supply since February, and the FDA's collaboration with Qilu Pharmaceutical aims to ramp up the drug's availability by importing it from China. The medication will be distributed in the US through Canada-based drugmaker Apotex. The FDA is also exploring the possibility of importing carboplatin, another chemotherapy drug facing shortages.